Sign up Australia
Proactive Investors - Run By Investors For Investors

Novita Healthcare's cognitive research to attract grant

The halt will remain in place until Friday 8th December 2017.
Novita Healthcare's cognitive research to attract grant
The company's shares are in pre-open

Novita Healthcare Ltd (ASX:NHL) has a unique focus using proprietary software algorithms to monitor and assist in the treatment of cognitive problems such as attention difficulties in early childhood.

Novita also has technology that provides a solution for care or support professionals looking for employment and for aged care or disability support providers needing staff.

The company has been granted a trading halt by the ASX this morning, pending details of a significant research grant.

The halt will remain in place until the opening of trade on Friday 8th December 2017, or earlier if an announcement is made to the market.





Register here to be notified of future . Company articles
View full . profile View Profile

Proactive Investors Australia Timeline

Newswire
November 29 2017

Related Articles

picture of text
July 28 2017
Dotdigital has been named as one of the fastest growing companies in Europe
marketing
November 16 2017
Next Fifteen Communications expects another strong performance in the second half
picture of Hunger Games cast
November 27 2017
Some of the most famous films ever made have been backed by FFI since it was founded in 1950

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use